A detailed history of Avoro Capital Advisors LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 8,060,000 shares of OCUL stock, worth $83.7 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
8,060,000
Previous 7,148,936 12.74%
Holding current value
$83.7 Million
Previous $65.1 Million 15.26%
% of portfolio
0.75%
Previous 0.78%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.2 - $8.69 $3.83 Million - $7.92 Million
911,064 Added 12.74%
8,060,000 $55.1 Million
Q1 2024

May 15, 2024

BUY
$3.85 - $10.93 $27.5 Million - $78.1 Million
7,148,936 New
7,148,936 $65.1 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $800M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.